Parkinson Disease
Showing NaN - NaN of 48
Parkinson Disease Trial in Worldwide (ExAblate Pallidotomy, Sham ExAblate Pallidotomy)
Active, not recruiting
- Parkinson Disease
- ExAblate Pallidotomy
- Sham ExAblate Pallidotomy
-
Stanford, California
- +19 more
Nov 5, 2020
Parkinson Disease Trial in London (Ambroxol)
Completed
- Parkinson Disease
-
London, United KingdomLeonard Wolfson Experimental Neurology Centre Clinical Research
Apr 14, 2020
Parkinson Disease, Speech Disorders Trial in London (Speech-in-Noise Treatment Program, Speech-to-Noise Feedback Device Program)
Unknown status
- Parkinson Disease
- Speech Disorders
- Speech-in-Noise Treatment Program
- Speech-to-Noise Feedback Device Program
-
London, Ontario, CanadaLawsonHRI
Mar 24, 2020
Underlying Biochemical Pathways Involved in Parkinson's Disease,
Unknown status
- Parkinson Disease
- Parkinsonism
-
London, United KingdomUCL Institute of Neurology, Department of Clinical Neurosciences
Mar 25, 2020
Parkinson Disease Trial in Worldwide (Placebo oral capsule, PXT002331 - dose 1, PXT002331 - dose 2)
Completed
- Parkinson Disease
- Placebo oral capsule
- +2 more
-
Innsbruck, Austria
- +44 more
Mar 16, 2020
Molecular Pathology and Neuronal Networks in LRRK2 Parkinson's
Unknown status
- Parkinson Disease, PARK8
- +2 more
-
London, United KingdomKing's College London
Jan 24, 2020
Parkinson Disease, Anxiety Trial in London (Interpretation bias training)
Unknown status
- Parkinson Disease
- Anxiety
- Interpretation bias training
-
London, United KingdomKing's College London
Oct 30, 2019
The Ontario Neurodegenerative Disease Research Initiative
Completed
- Alzheimer Disease
- +4 more
- Observational Cohort
-
Hamilton, Ontario, Canada
- +11 more
Sep 23, 2019
Parkinson Disease Trial in London (Active tPCS, Sham tPCS, Levodopa tablet)
Unknown status
- Parkinson Disease
- Active tPCS
- +2 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Aug 12, 2019
Parkinson Disease Trial in London, Oxford (Alternating DBS)
Unknown status
- Parkinson Disease
- Alternating DBS
-
London, United Kingdom
- +1 more
Aug 5, 2019
Parkinson Disease Trial in London (Speech-to-noise feedback)
Unknown status
- Parkinson Disease
- Speech-to-noise feedback
-
London, Ontario, CanadaLawsonHRI
Feb 7, 2019
Nigrosomal Iron Imaging in Parkinson's Disease
Unknown status
- Parkinson Disease
- Patient assessment
- +3 more
-
Derby, Derbyshire, United Kingdom
- +2 more
Oct 11, 2018
Help-seeking for Health Problems in People With Parkinson's
Completed
- Parkinson Disease
- Help-seeking for non-motor symptoms
-
London, United KingdomCity, University of London
Jan 29, 2018
Parkinson Disease Trial in Worldwide (Pramipexol Extended Release, Pramipexol Immediate Release, Placebo)
Completed
- Parkinson Disease
- Pramipexol Extended Release
- +2 more
-
Linz, Austria
- +75 more
Jun 24, 2014
Impulse Control Disorders in Parkinson's Patients Treated With
Completed
- Parkinson Disease
-
Gilbert, Arizona
- +48 more
Nov 11, 2013
Parkinson Disease Trial in Canada, United States (Coenzyme Q10 with vitamin E, with vitamin E)
Terminated
- Parkinson Disease
- Coenzyme Q10 with vitamin E
- placebo with vitamin E
-
Birmingham, Alabama
- +67 more
Dec 24, 2012
Parkinson Disease, Depression Trial in Canada, Puerto Rico, United States (paroxetine, venlafaxine, )
Completed
- Parkinson Disease
- Depression
- paroxetine
- +2 more
-
San Francisco, California
- +17 more
Jan 3, 2013
Parkinson Disease Trial in Canada, Puerto Rico, United States (CEP-1347 10mg, CEP1347 25mg, CEP-1347 50mg)
Terminated
- Parkinson Disease
- CEP-1347 10mg
- +3 more
-
Phoenix, Arizona
- +65 more
May 8, 2012
Parkinson's Research: The Organized Genetics Initiative
Completed
- Parkinson Disease
-
Phoenix, Arizona
- +57 more
Feb 15, 2011
PRECEPT Study Cohort
Unknown status
- Parkinson Disease
-
Phoenix, Arizona
- +54 more
Mar 26, 2008